Push Admin

'Acceptable' for Chinese COVID-19 vaccine to have 50-percent efficacy- DOST

Article (news)

Jamaine Punzalan, ABS-CBN News

<div class="embed-wrap"><figure data-feedback="fb:likes,fb:comments"><img src="http://sa.kapamilya.com/absnews/abscbnnews/media/2020/reuters/12/24/20201224-brazil-vaccine-coronavirus-rtr.jpg?ext=.jpg"/><figcaption>Doctor Tatiana Maria Pereira Fernandes receives an injection as she is a volunteer in the Coronavac&#x27;s trial, SinoVac&#x27;s coronavirus disease (COVID-19) vaccine at Emilio Ribas Institute, in Sao Paulo, Brazil December 11, 2020. Picture taken Dec. 11, 2020. <em>Amanda Perobelli, Reuters</em></figcaption></figure></div><p>MANILA — The reported 50-percent efficacy of the COVID-19 vaccine from China&#x27;s Sinovac is &quot;acceptable&quot; as this is the minimum requirement for use, the Department of Science and Technology said on Thursday. </p><p>A newspaper in Brazil, where late-stage trials of the Sinovac vaccine are running, reported that the drug was over 50% effective. The vaccine is among those the Philippines is eyeing to procure for inoculations here. </p><ul class="op-related-articles">	<li><a href="https://news.abs-cbn.com/news/12/17/20/philippines-eyes-4-coronavirus-vaccines-in-first-quarter-2021">Philippines eyes 4 coronavirus vaccines in first quarter 2021</a></li></ul><p>“The 50-percent efficacy is acceptable because that is the minimum requirement set by the World Health Organization for a vaccine to be used by the country,” said Jaime Montoya, executive director of the DOST-Philippine Council for Health Research and Development. </p><p>“We have to also bear in mind that the vaccine efficacy may actually change, it may go up or it may go down, as more and more people are using it when they are actually rolled out,” he said. <br/> <br/>The reported efficacy is for &quot;overall&quot; participants and could be higher &quot;if we actually break them down into groups,&quot; he said. </p><p>“Maybe it is more effective in a particular group of people – maybe health care workers, maybe in the elderly, maybe with those with co-existing morbidity so we have to look at them,” Montoya said. “So we have to also look at where they are actually going to be most useful, in what group, before we can actually make a decision.” </p><p>“Until such time na na-review natin ang (that we review) data, we cannot make any conclusion,”  he added. </p><p>Other vaccine candidates from Pfizer and Moderna, which reported 95 and 94.5 percent efficacy, respectively, have secured emergency use authorization (EUA) in the US, said Montoya. </p><ul class="op-related-articles">	<li><a href="https://news.abs-cbn.com/overseas/12/09/20/pfizer-vaccine-raises-no-specific-safety-concerns-us-regulator">Pfizer vaccine raises &#x27;no specific safety concerns&#x27;: US regulator</a></li>	<li><a href="https://news.abs-cbn.com/overseas/12/19/20/us-authorizes-moderna-as-second-covid-19-vaccine">US authorizes Moderna as second COVID-19 vaccine</a></li></ul><p>“If they are going to pursue their application here in the Philippines for the EUA… then malamang sila ang mauuna maging (they will likely be first to become) available,” he said. </p><p>“If we are given a choice and we have to prioritize, of course, definitely the vaccine efficacy [that] is higher would be the preferred vaccine,” added the official.</p><ul class="op-related-articles">	<li><a href="https://news.abs-cbn.com/news/12/16/20/lacson-says-cabinet-member-dropped-the-ball-in-vaccine-deal-with-pfizer">Lacson says Duque &#x27;dropped the ball&#x27; in vaccine deal with Pfizer</a></li>	<li><a href="https://news.abs-cbn.com/news/12/16/20/duque-amid-questions-on-china-covid-19-vaccine-trust-screening-process">Duque amid questions on China COVID-19 vaccine: Trust screening process</a></li></ul><p>The Philippines, which has tallied some 464,000 coronavirus infections, is eyeing 4 vaccines for use in the first quarter of 2021, including Russia&#x27;s Gamaleya Institute and China&#x27;s Sinovac, Sinopharm and CanSino. </p><figure class="op-interactive"><iframe height="315" src="https://www.youtube.com/embed/8LiQhfZHvCM?enablejsapi=1" width="560"></iframe></figure><div class="iwantbar"><div><em>Video courtesy of PTV</em></div></div>

<p>The reported 50-percent efficacy of the COVID-19 vaccine from China's Sinovac is "acceptable", the Department of Science and Technology said on Thursday. </p>

The reported 50-percent efficacy of the COVID-19 vaccine from China's Sinovac is "acceptable", the Department of Science and Technology said on Thursday.

'Acceptable' for Chinese COVID-19 vaccine to have 50-percent efficacy- DOST

News

Entertainment

Lifestyle

Sports

Metro.Style

More

Traffic

Manila

Horoscope

News

'Acceptable' for Chinese COVID-19 vaccine to have 50-percent efficacy- DOST

Jamaine Punzalan,

ABS-CBN News

Published Dec 24, 2020 01:11 PM PHT

|

Updated Dec 24, 2020 01:21 PM PHT

Read More:

China

China Philippines

China COVID

China coronavirus

China Sinovac

China vaccine

Sinovac vaccine

ABS-CBN is the leading media and entertainment company in the Philippines, offering quality content across TV, radio, digital, and film. Committed to public service and promoting Filipino values, ABS-CBN continues to inspire and connect audiences worldwide.

Corporate

Investors

Governance

International Distribution

Corporate

Governance

Investors

International Distribution

NPC Seal of Registration

Privacy Policy

AI Policy

Terms of Service

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.